Biotech Regulatory Solutions presented at a session at ARCS Annual Scientific Conference in Sydney May 2015 on Module 3 requirements for biologics Key note speaker from the Therapeutic Goods Administration (TGA).
Archive | Latest News
RSS feed for this sectionUSA FDA has accepted Sandoz application for biosimilar filgrastim
On the 24th July 2014 Sandoz announced that the USA FDA has accepted Sandoz application for biosimilar filgrastim.
Biosimilar session at the ARCS Scientific Congress
Biotech Regulatory Solutions are chairing a biosimilar session at the ARCS Scientific Congress in Canberra September 2014